← FDA Drug Approvals (Drugs@FDA)
RISPERDAL CONSTA
NDA · New Drug Application · Sponsor: JANSSEN PHARMS · Approved 2003-10-29
Drug application
- FDA Application #
NDA021346- Application type
- New Drug Application
- Brand name
- RISPERDAL CONSTA
- Generic name
- RISPERIDONE
- Active ingredients
- RISPERIDONE
- Dosage form
- POWDER
- Route
- INTRAMUSCULAR
- Marketing status
- Prescription
- Sponsor
- JANSSEN PHARMS
- Manufacturer
- Janssen Pharmaceuticals, Inc.
- First approval
- 2003-10-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown